» Articles » PMID: 32337143

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update

Overview
Journal Cureus
Date 2020 Apr 28
PMID 32337143
Citations 355
Authors
Affiliations
Soon will be listed here.
Abstract

Coronaviruses (CoVs) belong to the family of Coronaviridae, the order Nidovirales, and the genus Coronavirus. They are the largest group of viruses causing respiratory and gastrointestinal infections. Morphologically, CoVs are enveloped viruses containing a non-segmented positive-sense, single-stranded ribonucleic acid (RNA) viruses. CoVs are categorized into four important genera that include Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus. A novel member of human CoV that has recently emerged in Wuhan, China, is now formally named as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This is a unique strain of RNA viruses that have not been previously observed in humans. The virus has wide host adaptability and is capable of causing severe diseases in humans, masked palm civets, mice, dogs, cats, camels, pigs, chickens, and bats. The SARS-CoV-2 typically causes respiratory and gastrointestinal sickness in both humans and animals. It can be transmitted through aerosols and direct/indirect contact, as well as during medical cases and laboratory sample handling. Specific structural proteins, which might be found on the surface of the virus, play an important role in the pathogenesis and development of the complications. The disease is characterized by distinct medical signs and symptoms that include high fever, chills, cough, and shortness of breath or difficulty in breathing. The infected people may also present with other symptoms such as diarrhea, myalgia, fatigue, expectoration, and hemoptysis. It is important from the public health and economic point of view as it affects the growth of the country, which is majorly attributed to the restriction in the movement of the people and the cost associated with the control and prevention of the disease. Since there is no specific therapeutic intervention nor a vaccine available against the virus, supportive management and treatment with non-specific therapeutic agents (repurposed drugs) may provide relief to the patients. Some preventive strategies of the disease include blocking the routes of transmission of the infections, disinfection of instruments used during medical case handling, using personal protective equipment, proper and early diagnosis of the disease, avoiding contact with the sick patients, and quarantine of the infected/exposed people.

Citing Articles

Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay.

Sinsulpsiri S, Nishii Y, Xu-Xu Q, Miura M, Wilasluck P, Salamteh K Sci Rep. 2025; 15(1):6956.

PMID: 40011571 PMC: 11865625. DOI: 10.1038/s41598-025-91235-1.


The effect of cysteine oxidation on conformational changes of SARS-CoV-2 spike protein using atomistic simulations.

Ghasemitarei M, Taeb H, Ghorbi T, Yusupov M, Ala-Nissila T, Bogaerts A Sci Rep. 2025; 15(1):6890.

PMID: 40011543 PMC: 11865280. DOI: 10.1038/s41598-025-90918-z.


Comparative Analysis of Virology and Pathogenesis of SARS-CoV-2 and HIV Infections: Implications for Public Health and Treatment Strategies.

Olebo D, Igwe M Infect Drug Resist. 2025; 18():269-283.

PMID: 39835166 PMC: 11742764. DOI: 10.2147/IDR.S498430.


IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2.

Lee C, Khan R, Mantsounga C, Sharma S, Pierce J, Amelotte E bioRxiv. 2025; .

PMID: 39763770 PMC: 11703209. DOI: 10.1101/2024.12.24.630260.


Combating COVID-19 and its co-infection by Aspergillus tamarii SP73-EGY using in vitro and in silico Studies.

Abdelsalam E, Ibrahim A, El-Rashedy A, Abdel-Aziz M, Kutkat O, El-Hady F Sci Rep. 2025; 15(1):685.

PMID: 39753574 PMC: 11698736. DOI: 10.1038/s41598-024-77854-0.


References
1.
Barcena M, Oostergetel G, Bartelink W, Faas F, Verkleij A, Rottier P . Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A. 2009; 106(2):582-7. PMC: 2613939. DOI: 10.1073/pnas.0805270106. View

2.
Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

3.
Beutels P, Jia N, Zhou Q, Smith R, Cao W, de Vlas S . The economic impact of SARS in Beijing, China. Trop Med Int Health. 2009; 14 Suppl 1:85-91. DOI: 10.1111/j.1365-3156.2008.02210.x. View

4.
Perlman S . Another Decade, Another Coronavirus. N Engl J Med. 2020; 382(8):760-762. PMC: 7121143. DOI: 10.1056/NEJMe2001126. View

5.
Hui D, Zumla A . Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019; 33(4):869-889. PMC: 7127569. DOI: 10.1016/j.idc.2019.07.001. View